Medco Buys DNA Direct To Bolster Its Personalized Medicine Business
This article was originally published in The Pink Sheet Daily
Executive Summary
DNA Direct adds genetic testing guidance and decision-support capacity to Medco's burgeoning personalized medicine portfolio.
You may also be interested in...
Genetic Testing For Tamoxifen, Warfarin, Plavix Lacks “Clear Value,” Express Scripts Says
Express Scripts’ caution about the cost effectiveness of some genetic testing could hint at how interested it will be in continuing the pharmacogenomic programs sponsored by former rival PBM Medco, which Express acquired in early April.
Medco, AssureRx Partner In Trial To Improve Psychotropic Medication Adherence Through Genetic Testing
Medco does not expect results to alter reimbursement decisions, but to offer another tool to help physicians make prescribing decisions.
Medco, AssureRx Partner In Trial To Improve Psychotropic Medication Adherence Through Genetic Testing
Medco does not expect results to alter reimbursement decisions, but to offer another tool to help physicians make prescribing decisions.